🇺🇸 FDA
Patent

US 7914788

Monoclonal antibodies against orthopoxviruses

granted A61KA61K2039/505A61K2039/545

Quick answer

US patent 7914788 (Monoclonal antibodies against orthopoxviruses) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/505, A61K2039/545, A61K39/00, A61P